Literature DB >> 397662

The natural course of active choroidal lesions in the presumed ocular histoplasmosis syndrome.

F A Gutman.   

Abstract

Eighty-two patients and 106 eyes with the POHS have been followed for one year or longer. Untreated active choroidal lesions were divided into groupings based on the distance from the center of the CFZ and the reltionship to the border of the CFZ. Twenty-three percent of untreated active choroidal lesions that were located inside the CFZ achieved 20/20 to 20/40 vision. Sixty-three percent of untreated active choroidal lesions that were located outside of the CFZ achieved a vision of 20/20 to 20/40. The active choroidal lesions with the best visual prognosis were 0.25 to 0.5 disc diamterers, demonstrated no growth, and had little or no associated choroidal bleeding. Activation of choroidal lesions in the fellow eye at the site of preexisting atrophic scars was documented in 21% of the eyes. One fellow eye developed a de novo active choroidal lesion. Eighteen percent of the cases had structurally congested nerve heads characterized by slight elevation of the disc and no physiologic depression; 3% of the eyes had drusen of the optic nerve. A relationship may exist between peripapillary scarring in the POHS and these nerve head changes.

Entities:  

Mesh:

Year:  1979        PMID: 397662      PMCID: PMC1311716     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  37 in total

1.  Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis.

Authors:  M L Klein; S L Fine; D L Knox; A Patz
Journal:  Am J Ophthalmol       Date:  1977-06       Impact factor: 5.258

2.  Focal choroidopathy in experimental ocular histoplasmosis.

Authors:  V G Wong
Journal:  Trans Am Ophthalmol Soc       Date:  1972

3.  Presumed ocular histoplasmosis. I. Histoplasmin skin test sensitivity in cases identified during a community survey.

Authors:  R E Smith; J P Ganley
Journal:  Arch Ophthalmol       Date:  1972-03

4.  Granulomatous choroiditis in a case of disseminated histoplasmosis. Histologic demonstration of Histoplasma capsulatum in choroidal lesions.

Authors:  G K Klintworth; A S Hollingsworth; P A Lusman; W D Bradford
Journal:  Arch Ophthalmol       Date:  1973-07

5.  Clinical course in rabbits after experimental induction of ocular histoplasmosis.

Authors:  R E Smith; G R O'Connor; C J Halde; M A Scalarone; W M Easterbrook
Journal:  Am J Ophthalmol       Date:  1973-08       Impact factor: 5.258

6.  Ocular histoplasmosis. Significance of asymptomatic macular scars.

Authors:  R E Smith; D L Knox; A D Jensen
Journal:  Arch Ophthalmol       Date:  1973-04

7.  Follow-up study of presumed ocular histoplasmosis.

Authors:  J D Gass; C P Wilkinson
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1972 May-Jun

8.  Photocoagulation of disciform macular lesions in the ocular histoplasmosis syndrome.

Authors:  A E Maumenee; S J Ryan
Journal:  Am J Ophthalmol       Date:  1973-01       Impact factor: 5.258

9.  Presumed ocular histoplasmosis. 3. Epidemiologic characteristics of people with peripheral atrophic scars.

Authors:  J P Ganley; R E Smith; D L Knox; G W Comstock
Journal:  Arch Ophthalmol       Date:  1973-02

10.  De novo lesions in presumed ocular histoplasmosis-like syndrome.

Authors:  S A Miller; T S Stevens; G de Venecia
Journal:  Br J Ophthalmol       Date:  1976-10       Impact factor: 4.638

View more
  3 in total

1.  Krypton red laser photocoagulation of peripapillary subretinal neovascular membranes.

Authors:  W H Annesley; H G Shah; A M Mansour; W L Decker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

2.  Idiopathic sub-retinal neovascular membranes in the macula (hemorrhagic macular choroidopathy of young adults). Clinical report and effectiveness of laser treatment.

Authors:  F G Bottoni; A F Deutman
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

3.  Argon laser photocoagulation of subretinal neovascular membranes.

Authors:  H L Little; R L Jack; A Vassiliadis
Journal:  Trans Am Ophthalmol Soc       Date:  1980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.